INS and pulmonary arterial hypertension: Recent studies in PAH patients reported a specific pattern of metabolic alterations, including insulin resistance defined as elevated triglyceride to HDL cholesterol ratio [34,59], glucose intolerance, and a blunted insulin response to an oral glucose load [60].